Altre lingue Hongchang International Co., Ltd

Azioni

HCIL

US42831T2024

Tempo differito OTC Markets Altri mercati azionari 15:30:45 08/03/2024			Variaz. 5gg	Var. 1 gen.
0,2226 ^USD	-.--%		-.--%	-36,18%

01/04	Hongchang International Co., Ltd riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
01/04	Hongchang International Co., Ltd annuncia cambiamenti nel Consiglio di Amministrazione	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hongchang International Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
Hongchang International Co., Ltd Announces Board Changes	01/04
Hongchang International Co., Ltd. has Changed its Ticker to HCIL from HYBT	28/11
Heyu Biological Technology Corporation has Changed its Name to Hongchang International Co., Ltd	21/11
Hongchang International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Hong Chang Biotechnologies (HK) Limited completed the acquisition of Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction.	04/09/23
Heyu Biological Technology Corporation Appoints Zengqiang Lin as the Chief Executive Officer	23/08/23
Heyu Biological Technology Corporation Announces Board and Executive Changes	23/08/23
Heyu Biological Technology Corporation Appoints Wendy Wei Li as the Chief Financial Officer of the Company	23/08/23
Hong Chang Biotechnologies (HK) Limited entered into an agreement to acquire Heyu Biological Technology Corporation (OTCPK:HYBT.D) in a reverse merger transaction for HKD 4.4 billion.	23/08/23
Heyu Biological Technology Corporation Reports Earnings Results for the Half Year Ended June 30, 2023	16/08/23
Insider Buy: Heyu Biological Technology	31/05/23
Heyu Biological Technology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23/03/23
Heyu Biological Technology Corporation Auditor Raises 'Going Concern' Doubt	23/03/23
HEYU BIOLOGICAL TECHNOLOGY : ANNOUNCES APPOINTMENT OF NEW INDEPENDENT DIRECTOR - Form 8-K	22/02/23
HEYU BIOLOGICAL TECHNOLOGY CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	22/02/23
Heyu Biological Technology Corporation Appoints Zengqiang Lin as an Independent Director of the Company	22/02/23
HEYU BIOLOGICAL TECHNOLOGY CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/02/23
Heyu Biological Technology Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	13/02/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hongchang International Co., Ltd

Azioni

HCIL

US42831T2024

Altre lingue

Filtri